docetaxel
BO22589
Approved small_molecule completed
Quick answer
docetaxel for Breast Cancer is a Approved program (small_molecule) at Hoffmann-La Roche with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Breast Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed